U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07290036) titled 'A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults' on Dec. 04.
Brief Summary: To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Psoriatic Arthritis; Axial Spondyloarthritis
Intervention:
DRUG: Bimekizumab regimen 1 iv
Participants will receive bimekizumab (BKZ) at pre-specified time points.
DRUG: Bimekizumab regimen 2 iv
Participants will receive bimekizumab (BKZ) at pre-specified time points.
DRUG: Bimekizumab regimen 3 sc
Part...